Virbac Stock Tests Its €332 Support Before Rebalancing
The veterinary laboratory in Carros is nearly balanced at midday, after a turbulent morning. The stock sought a closely watched technical threshold before recovering, in a stagnant Parisian market.
Support at €332 Breached During the Session Before Rising Above Again
Virbac stock is up 0.15% at €332.50 mid-session, after dropping to €327.50 in the morning. The stock briefly breached its €332 support before climbing back above, bringing the day's variation back to equilibrium. The lower wick movement reflects a buyer-seller tension around this level, which had served as a floor during the last consolidation sessions. Over the week, the stock has lost nearly 3%, and is down 5% over the month.
A Deteriorated Technical Setup, Below the Three Moving Averages
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The price remains below its three main moving averages: MM20 at €350.20 (a gap of -5.05%), MM50 at €358.06, and MM200 at €349.09. The RSI at 35 indicates seller fatigue that allowed the intraday rebound on the support. The next resistance is at €372, nearly 12% above the current price. The stock had already attempted to approach its MM200 on June 12, without managing to sustainably break through. The holding of the €332 threshold at closing will be the first marker of the session.
SectorSanté · Vaccins et laboratoires de recherche›Industrie Pharmaceutique
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 1T2026
Guidance from the release
Notre excellent début d'année souligne la force compétitive de notre modèle.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
